CAREDX, INC. Grants Receivable
CAREDX, INC. (CDNA) had Grants Receivable of $30.00 billion as of 2021-12-31, per its 10-K filed 2022-02-24.
Discontinued › Notes
us-gaap:GrantsReceivable · last filed 2022-02-24
- 2021-12-31: Grants Receivable $30.00B.
- 2021-09-30: Grants Receivable $30.00B.
- 2021-06-30: Grants Receivable $30.00B.
- 2021-03-31: Grants Receivable $30.00B.
| Period end | Grants Receivable |
|---|---|
| 2021-12-31 | $30.00B 10-K · filed 2022-02-24 |
| 2021-09-30 | $30.00B 10-Q · filed 2021-10-28 |
| 2021-06-30 | $30.00B 10-Q · filed 2021-07-29 |
| 2021-03-31 | $30.00B 10-Q · filed 2021-05-05 |
| 2019-12-31 | $30.00B 10-K · filed 2021-02-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Celcuity Inc. (CELC) | United States | $3.887B | -22.62 |
| VERACYTE, INC. (VCYT) | United States | $3.904B | 41.21 |
| Fortrea Holdings Inc. (FTRE) | United States | $1.903B | -19.43 |
| Personalis, Inc. (PSNL) | United States | $1.769B | -13.30 |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| GRAIL, Inc. (GRAL) | United States | $5.591B | -7.78 |
| RadNet, Inc. (RDNT) | United States | $5.611B | -229.65 |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| BIODESIX INC (BDSX) | United States | $0.312B |